Document Detail


Effective Inhibition of Human Immunodeficiency Virus 1 Replication by Engineered RNase P Ribozyme.
MedLine Citation:
PMID:  23300569     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Using an in vitro selection procedure, we have previously isolated RNase P ribozyme variants that efficiently cleave an mRNA sequence in vitro. In this study, a variant was used to target the HIV RNA sequence in the tat region. The variant cleaved the tat RNA sequence in vitro about 20 times more efficiently than the wild type ribozyme. Our results provide the first direct evidence that combined mutations at nucleotide 83 and 340 of RNase P catalytic RNA from Escherichia coli (G(83) -> U(83) and G(340) -> A(340)) increase the overall efficiency of the ribozyme in cleaving an HIV RNA sequence. Moreover, the variant is more effective in reducing HIV-1 p24 expression and intracellular viral RNA level in cells than the wild type ribozyme. A reduction of about 90% in viral RNA level and a reduction of 150 fold in viral growth were observed in cells that expressed the variant, while a reduction of less than 10% was observed in cells that either did not express the ribozyme or produced a catalytically inactive ribozyme mutant. Thus, engineered ribozyme variants are effective in inhibiting HIV infection. These results also demonstrate the potential of engineering RNase P ribozymes for anti-HIV application.
Authors:
Wenbo Zeng; Yuan-Chuan Chen; Yong Bai; Phong Trang; Gia-Phong Vu; Sangwei Lu; Jianguo Wu; Fenyong Liu
Related Documents :
2839209 - Seroepidemiological research on hepatitis a (ha) in the city of siena.
24974649 - Disseminated cryptococcosis in an hiv-seronegative pregnant woman with transient t-lymp...
23703729 - Epigenetic regulation of microrna-122 by peroxisome proliferator activated receptor-gam...
23111959 - Hiv-hcv co-infection: epidemiology, pathogenesis and therapeutic implications.
1515699 - Early in-vitro histological chondral differentiation.
23121249 - Influence of episodes of intermittent viremia ("blips") on immune responses and viral l...
15579279 - Substance p and neurokinin-1 receptor modulation of hiv.
22270759 - Analysis of the pkr-eif2alpha phosphorylation homology domain (pephd) of hepatitis c vi...
15698519 - Drug monitoring and viral response to lopinavir/ritonavir or saquinavir/ritonavir conta...
Publication Detail:
Type:  Journal Article     Date:  2012-12-26
Journal Detail:
Title:  PloS one     Volume:  7     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2012  
Date Detail:
Created Date:  2013-01-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e51855     Citation Subset:  IM    
Affiliation:
State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Trend in annual risk of tuberculous infection in north India.
Next Document:  Activation Mechanisms of Natural Killer Cells during Influenza Virus Infection.